BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported fourth-quarter adjusted EPS of 92 cents, up from 49 cents reported a year ago, beating the consensus of 53 cents. The company reported sales of $747 ...

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.64, expectations were $0.54. Operator: Ladies and gentlemen, thank you ...

SIRIM Berhad (SIRIM) and Ensu Lifesciences Sdn Bhd (ELSB) today signed a technology licensing agreement to produce the Acne and Blemish Control Skin Care Technology, a skincare product derived from ...

IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure.

BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...

Microsoft's Majorana 1 processor uses topological superconductivity to potentially scale quantum computing to 1 million ...

By integrating topoconductors and Majorana particles, Microsoft has mapped out a viable route to a million-qubit quantum chip ...

Patricia HanbidgeOrchid HorticultureWinter in the northern hemisphere gives us super short days and really long nights! Just ...

These useful findings assigned a novel functional implication of histone acylation, crotonylation. Although the mechanistic insights have been provided in great detail regarding the role of the YEATS2 ...

The CBSE Class 10 Science Exam 2025 was held on February 20, 2025. As per the initial student reactions, the paper was of ...